- CSL Behring (King Of Prussia, PA)
- …with conditions across immunology, hematology, cardiovascular and metabolic disease, respiratory disease, and transplant medicine. Our innovation is powered by ... platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy -helping address unmet medical needs and improve patients' lives worldwide.… more
- CSL Behring (King Of Prussia, PA)
- …with conditions across immunology, hematology, cardiovascular and metabolic disease, respiratory disease, and transplant medicine. Our innovation is powered by ... platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy -helping address unmet medical needs and improve patients' lives worldwide.… more
- CSL Behring (King Of Prussia, PA)
- …with conditions across immunology, hematology, cardiovascular and metabolic disease, respiratory disease, and transplant medicine. Our innovation is powered by ... platforms: plasma fractionation, recombinant protein technology, and cell and gene therapy -helping address unmet medical needs and improve patients' lives worldwide.… more
- CSL Behring (King Of Prussia, PA)
- …for the CSL portfolio. . You will lead forecasting projects across Hematology CSL therapy area. This role will be the direct point of contact for all forecasting ... living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific… more
- CSL Behring (King Of Prussia, PA)
- …and Analytics for Cardiovascular and Renal (CVR) and Transplant and Immunology (T&I) therapy areas + In this role, you will drive decision-making across all BD&L ... living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
- CSL Behring (King Of Prussia, PA)
- …living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory , and transplant therapeutic areas. We use three strategic scientific ... platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which… more
